At list price, Ozempic runs about $969–$998/month and Wegovy about $1,349/month — but almost nobody uninsured pays list. Both now have NovoCare self-pay routes from ~$199/month introductory (Wegovy about $349/month for maintenance doses), and Wegovy also has a $149/month oral pill. Prices change often — confirm current NovoCare pricing.
Both contain the same active ingredient, semaglutide. For weight loss on a cash budget, the Wegovy routes — or compounded semaglutide (from about $69/month, not FDA-approved) — are generally cheaper than paying Ozempic’s cash price. Estimates as of July 2026.